These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16840775)

  • 1. Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.
    Matsuoka H; Sisson TH; Nishiuma T; Simon RH
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):705-13. PubMed ID: 16840775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.
    Hattori N; Mizuno S; Yoshida Y; Chin K; Mishima M; Sisson TH; Simon RH; Nakamura T; Miyake M
    Am J Pathol; 2004 Mar; 164(3):1091-8. PubMed ID: 14982862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.
    Bauman KA; Wettlaufer SH; Okunishi K; Vannella KM; Stoolman JS; Huang SK; Courey AJ; White ES; Hogaboam CM; Simon RH; Toews GB; Sisson TH; Moore BB; Peters-Golden M
    J Clin Invest; 2010 Jun; 120(6):1950-60. PubMed ID: 20501949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
    Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B
    Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.
    Sisson TH; Nguyen MH; Yu B; Novak ML; Simon RH; Koh TJ
    Blood; 2009 Dec; 114(24):5052-61. PubMed ID: 19812386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
    Wang H; Zhang Y; Heuckeroth RO
    FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
    Hattori N; Degen JL; Sisson TH; Liu H; Moore BB; Pandrangi RG; Simon RH; Drew AF
    J Clin Invest; 2000 Dec; 106(11):1341-50. PubMed ID: 11104787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury.
    Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S
    Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
    Shimizu M; Hara A; Okuno M; Matsuno H; Okada K; Ueshima S; Matsuo O; Niwa M; Akita K; Yamada Y; Yoshimi N; Uematsu T; Kojima S; Friedman SL; Moriwaki H; Mori H
    Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.
    Bhandary YP; Shetty SK; Marudamuthu AS; Ji HL; Neuenschwander PF; Boggaram V; Morris GF; Fu J; Idell S; Shetty S
    Am J Pathol; 2013 Jul; 183(1):131-43. PubMed ID: 23665346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
    Wang H; Zhang Y; Heuckeroth RO
    Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
    Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
    Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis.
    Horowitz JC; Rogers DS; Simon RH; Sisson TH; Thannickal VJ
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):78-87. PubMed ID: 17656680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H; Vohra BP; Zhang Y; Heuckeroth RO
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.
    Naldini L; Tamagnone L; Vigna E; Sachs M; Hartmann G; Birchmeier W; Daikuhara Y; Tsubouchi H; Blasi F; Comoglio PM
    EMBO J; 1992 Dec; 11(13):4825-33. PubMed ID: 1334458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.